Angina pectoris
Conditions
Interventions
NOBORI Biolimus A9-eluting stent
Sponsors
The society of lipid lowering therapy
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Significant stenosi at right coronary artery ostial (within 10mm from ostial) 2) Vessel diameter > 2.5mm 3)
Exclusion criteria
Exclusion criteria: 1) Right coronary artery in which other drug-eluting stent has been implanted. 2) Myocardial infarction within 7 days 3) Chronic total occlusion 4) Female with pregnant 5) Chronic renal failure (SCr.3.0) 6) Patients with malignant diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| MACE (Cardiac death, Q-waveMI, Target lesion revascularization, Target vessel revascularization) at 12 month | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Inhospital MACE 2) Cardiac death at 12 month 3) Myocardial infarction at 12 month 4) Target lesion revascularization at 12 month 5) Target vessel revascularization at 12 month | — |
Countries
Japan
Contacts
Public ContactKenya Nasu
Toyohashi Heart Center Cardiology
Outcome results
None listed